$EUDA

EUDA Health Holdings GAAP EPS of -$0.33, revenue of $3.06M (NASDAQ:EUDA)

EUDA Health Holdings reported a GAAP EPS of -$0.33 and revenue of $3.06M for the first half, a 11.8% year-over-year decline. The company's stock price fell 1.84% following the earnings release.

Original reporting
Published Sep 29, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EUDA
Bearish
medium confidence
Mentioned
$EUDA
Relevance
6/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$EUDABearishMed
01

Why it matters

The earnings miss may trigger a short‑term price decline, but investors should watch for any forward‑looking guidance or catalyst announcements.

02

Market read

Micro‑cap earnings miss with negative EPS and revenue decline; likely short‑term downside for EUDA.

03

What to watch

Potential upcoming regulatory approvals or partnership announcements could offset the earnings weakness.

Relevance 6/10Novelty 6/10Timing: after-hours

Background

EUDA Health Holdings is a small NASDAQ‑listed health‑services company releasing its first‑half earnings.

Company-level read

Ticker impact

$EUDABearishMedium confidence
Context

EUDA Health Holdings reported 1H GAAP EPS of -$0.33 and revenue of $3.06M, a 11.8% YoY decline.

Expected impact

likely downside pressure as the market prices in weak earnings

Evidence & confidence

Micro‑cap earnings miss with negative EPS and declining revenue typically triggers sell‑offs, especially given the modest scale of the business.

Market effects

Health‑services micro‑caps may see broader sentiment drag if earnings miss is seen as sector‑wide pressure.

Limited to U.S. OTC/NASDAQ micro‑cap segment; no broader regional effect.

Minimal global impact due to company size and niche focus.

Counterpoint

If the company has pipeline catalysts not reflected in the short‑term numbers, the dip could be a buying opportunity.

Key entities

  • EUDA Health Holdings

    NASDAQ‑listed health‑services firm reporting 1H results.

Related articles

$BACMed

Bank of America's bad news may not be what investors think

Bank of America (BAC) reported Q3 2026 revenue of $30B, up 3% YoY but below estimates, with a $1.2B fine for compliance failures. Earnings were $0.91 per share, missing expectations. Morgan Stanley cut its price target to $61 and adjusted EPS estimates. Shares have fallen 5.36% YTD. Fixed income revenue dropped 17%, while equities saw record revenue growth.

$GLASHigh

Glass House Brands Inc. (GLAS): Financial results for Q3 2026

Glass House Brands Inc. (GLAS) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Glass House Brands Reports Preliminary Unaudited Third Quarter Financial Results and Resignation of John Nichols Jr. from Board of Directors • Achieved Record Biomass Production of approximately 317,000 pounds and a further approximately 10% reduction in cost of prod

$EOSEHigh

Why EOS Energy Soared as Much as 11% Today

EOS Energy (EOSE) shares initially rose 11% after reporting preliminary Q3 2026 results, including projected revenue of $82M-$83M (169%-172% YoY growth) and a gross profit margin of -55% to -53%. The stock later retreated 2.3%. The company also reported an 18.8% YoY increase in backlog to $765M. Full Q3 results are due Nov. 5.

$CLFHighAI 9/10

Cliffs Q3 2026 earnings beat estimates on $612M EBITDA

Cleveland-Cliffs reported Q3 2026 adjusted EBITDA of $612M, exceeding guidance and Q2 results. Revenue rose to $5.61B. CEO Goncalves cited improved pricing and volumes. EPS beat estimates. Stock climbed 14% pre-market. Q4 EBITDA expected near $715M, with 2027 forecasted above $4B. Stelco, its Canadian unit, performed strongly but idled galvanizing lines due to market conditions.